Browse by Person

Article

Corrie, P.G., Marshall, A., Nathan, P.D. et al. (36 more authors) (2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8). pp. 1843-1852.

Faivre-Finn, C., Snee, M., Ashcroft, L. et al. (17 more authors) (2017) Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet Oncology. ISSN 1470-2045

Shah, M.H., Lorigan, P., O'Brien, M.E. et al. (5 more authors) (2016) Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors. Investigational New Drugs, 34 (3). pp. 290-299. ISSN 0167-6997

Ahmad, S.S., Qian, W., Ellis, S. et al. (26 more authors) (2015) Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients. Melanoma Research, 25 (5). pp. 432-442. ISSN 0960-8931

Corrie, P., Marshall, A., Dunn, J. et al. (17 more authors) (2014) Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. Lancet Oncology, 15 (6). pp. 620-630. ISSN 1470-2045

Monograph

Beard, S.M., Lorigan , P., Sampson, F. et al. (1 more author) (1998) The Effectiveness of High Dose Chemotherapy and Autologous Stem Cell Transplantation in the Treatment of Non-Hodgkin’s Lymphoma and Hodgkin’s Disease. Other. Guidance Note for Purchasers (98/04). Trent Institute for Health Services Research, Universities of Leicester, Nottingham and Sheffield , Sheffield. ISSN 1900733234